Topical bevacizumab for the treatment of corneal vascularization in dogs: A case series.

Objective: To evaluate the effect and safety of topical anti-human vascular endothelial growth factor bevacizumab in dogs with persistent corneal vascularization.

Animals Studied: Prospective case series of 15 adult dogs (20 eyes).

Procedures: Dogs received 0.